Molluscum contagiosum: Its clinical, histopathologic, and immunohistochemical spectrum

International Journal of Dermatology

Volumn 38, Issue 9, 1999, Pages 664-672

  Smith, Kathleen J ^a   Yeager, Josef ^b   Skelton, Henry ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; IMIQUIMOD;

ADULT; CHILD; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLLUSCIPOXVIRUS; MOLLUSCUM CONTAGIOSUM; REVIEW; VERRUCA VULGARIS;

ADOLESCENT; ADULT; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLLUSCUM CONTAGIOSUM; MOLLUSCUM CONTAGIOSUM VIRUS; S100 PROTEINS; SKIN;

EID: 0032883007     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00677.x     Document Type: Review

References (28)

1. Gottleib SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol 1994; 33: 453-461.
2. Epstein WL. Molluscum contagiosum. Semin Dermatol 1991; 11: 184-189.
3. Lewis EJ, Larn M, Crutchfield CE. An update on molluscum contagiosum. Cutis 1997; 60: 29-34.
4. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27: 583-588.
5. Senkevich TG, Bugert JJ, Sisler JT, et al. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 1996; 273: 813-816.
6. Yamashita H, Uemura T, Kawashima M. Molecular epidemiologic analysis of Japanese patients with molluscum contagiosum. Int J Dermatol 1996; 35: 99-105.
7. Kunkel S, Stricter R, Linddley IJD, Westwick J. Chemokines, new ligands, receptors and activities. Immunol Today 1995; 16: 559-561.
8. Smith KJ, Skelton HG, Yeager J, et al. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol 1994; 31: 747-754.
9. Mark R, Buller L, Burnett J, et al. Replication of molluscum contagiosum. Urology 1995; 213: 655-659.
10. Porter CD, Blake NW, Carchard LC, et al. Molluscum contagiosum. Br J Dermatol 1989; 120: 37-41.
11. Nakamura J, Muraki Y, Yamada Y, et al. Analysis of molluscum contagiosum virus genomes isolated in Japan. J Med Virol 1995; 46: 339-348.
12. Meini E, Fickenscher H, Thome M, et al. Anti-apoptotic strategies of lymphotropic viruses. Immunol Today 1998; 19: 474-479.
13. Porter CD, Blake NW, Archard LC. Structure and activity of epidermal-growth-factor-like peptides: induction of basal cell proliferation by a poxvirus gene product? Bio Soc Trans 1988; 16: 671-674.
14. Porter CD, Archard LC. Characterization and physical mapping of molluscum contagiosum virus DNA and location of a sequence capable of encoding a conserved domain of epidermal growth factor. J Gen Virol 1987; 68: 673-682.
15. Suster S, Fisher C. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 1997; 21: 195-200.
16. Clerici M, Shearer GM. A Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575-581.
17. Romagnani S, Del Prete G, Ravina MA, et al. Role of Th1/Th2 cytokines in HIV infection. Immunol Rev 1994; 140: 73-92.
18. Kristal L, Clark RAF. Atopic dermatitis. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, eds. Cutaneous Medicine and Surgery. Philadelphia: WB Saunders, 1996: 195-204.
19. Smith KJ, Skelton HG, Frissman DM, Angritt P. Military Medical Consortium for Applied Retroviral Research (MMCARR). Verrucous lesions secondary to DNA viruses in HIV infected patients in association with increased Factor XIIIa positive dermal dendritic cells. J Am Acad Dermatol 1991; 27: 943-950.
20. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RNATES, MIP-1β, and MIP-1α as the major HIV suppressive factors produced by CD8+ T cells. Science 1995; 270: 1881-1815.
21. Plekoff D, Tretcute C, Brelot A, et al. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997; 276: 1874-1876.
22. Doranz BJ, Berson JF, Rucker J, Boms RW. Chemokine receptors as fusin cofactors for human immunodeficiency virus type 1 (HIV-1). Immunol Res 1997; 16: 15-18.
23. Blaul CC, Wu L, Hoxie JA, et al. The HIV coreceptors CXCR4 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997; 94: 1925-1930.
24. Simmons G, Claptam PR, Picard L, et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997; 176: 276-279.
25. Sorensen AM, Katzenstein T, Dickmeiss E, et al. Heterozygosity for a deletion in the CCR5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;3: 305-310.
26. Reiter MJ, Testerman TL, Miller RL, et al. Cytokine induction in mice by the immunomodulator imiquimod. J Leuk Biol 1994; 55: 234-240.
27. Kondo T, Kondo S, Pastore S, et al. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res 1994; 13: 71-76.
28. Davies EG, Thrasher A, Lacey K, Harper J. Topical cidofovir for severe molluscum contagiosum. Lancet 1999; 353: 2042.